Skip to main content

Table 1 General information of included pediatric patients

From: Routine administration of neostigmine after recovery of spontaneous breathing versus neuromuscular monitor-guided administration of neostigmine in pediatric patients: a parallel, randomized, controlled study

Variables

Experimental group (n=60)

Control group (n=60)

p-value

General characteristics

 Sex (male/female), No.

48/12

45/15

0.51

 Age (years), mean ± SD

3.5 ± 1.9

4.0 ± 2.2

0.29

 Body weight (kg), mean ± SD

16.1 ± 4.3

17.1 ± 5.8

0.28

 Surgical time (min), mean ± SD

18.1 ± 8.0

16.9 ± 6.2

0.38

 Anesthesia time (min), mean ± SD

36.9 ± 9.9

35.2 ± 9.0

0.33

Intraoperative Medications

 Cis-atracurium (mg), mean ± SD

1.4 ± 0.5

1.6 ± 1.0

0.14

 Fentanyl (ug), mean ± SD

38.9 ± 12.9

40.5 ± 11.6

0.48

 Ondansetron (mg), mean ± SD

1.6 ± 0.7

1.8 ± 1.1

0.29

Respiration state before extubation

 Respiratory rate (bpm), mean ± SD

19.3 ± 5.6

19.4 ± 4.5

0.94

 Tidal volume (ml), mean ± SD

124.9 ± 51.8

135.2 ± 60.3

0.32

 Pulse oxygen saturation (%), mean ± SD

99.7 ± 0.9

99.9 ± 0.3

0.13

 End-tidal carbon dioxide (mmHg), mean ± SD

45.6 ± 6.6

45.5 ± 6.0

0.94

  1. min minute, bpm breath per minute